2022

Daridorexant

by cyb2025

RODRIGO O. M. A DE SOUZA
Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

We would like to introduce the new column that arrives in our first issue of 2022 called “API of the Month”. This initiative will disclose the chemistry steps needed to synthesize recent FDA (Food and Drug Administration) approved active pharmaceutical ingredients (API). This month we will focus on Daridorexant. We invite our readers to send us comments and requests on specific ingredients you would like to learn more on in this column.

 

 

ABOUT THE AUTHOR

Rodrigo O. M. A de Souza – Since I started my independent career, I have pursuit the development of new technologies to guide research by innovative ideas. We have been working at Federal University of Rio de Janeiro on the establishment of continuous-flow technology for active pharmaceutical ingredients (API) synthesis in Brazil, showing that is possible to reduce costs on production allowing the reduction of the final price of the medicine.

Login